WO2009062746A3 - Topische arzneimittel zur antimykotischen therapie - Google Patents
Topische arzneimittel zur antimykotischen therapie Download PDFInfo
- Publication number
- WO2009062746A3 WO2009062746A3 PCT/EP2008/009686 EP2008009686W WO2009062746A3 WO 2009062746 A3 WO2009062746 A3 WO 2009062746A3 EP 2008009686 W EP2008009686 W EP 2008009686W WO 2009062746 A3 WO2009062746 A3 WO 2009062746A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- topical drugs
- antifungal therapy
- antifungal
- drugs
- active substance
- Prior art date
Links
- 230000000843 anti-fungal effect Effects 0.000 title abstract 3
- 229940121375 antifungal agent Drugs 0.000 title abstract 3
- 229940079593 drug Drugs 0.000 title abstract 3
- 239000003814 drug Substances 0.000 title abstract 3
- 238000002560 therapeutic procedure Methods 0.000 title abstract 2
- 230000000699 topical effect Effects 0.000 title abstract 2
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 abstract 2
- 239000013543 active substance Substances 0.000 abstract 2
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 abstract 1
- 229940055726 pantothenic acid Drugs 0.000 abstract 1
- 235000019161 pantothenic acid Nutrition 0.000 abstract 1
- 239000011713 pantothenic acid Substances 0.000 abstract 1
- 150000002948 pantothenic acids Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
- A61K31/10—Sulfides; Sulfoxides; Sulfones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/164—Amides, e.g. hydroxamic acids of a carboxylic acid with an aminoalcohol, e.g. ceramides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4174—Arylalkylimidazoles, e.g. oxymetazolin, naphazoline, miconazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4196—1,2,4-Triazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/513—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA2705815A CA2705815A1 (en) | 2007-11-17 | 2008-11-15 | Topical drugs for use in antifungal therapy |
EP08850735A EP2222319A2 (de) | 2007-11-17 | 2008-11-15 | Topische arzneimittel zur antimykotischen therapie |
AU2008323165A AU2008323165A1 (en) | 2007-11-17 | 2008-11-15 | Topical drugs for use in antifungal therapy |
MX2010005385A MX2010005385A (es) | 2007-11-17 | 2008-11-15 | Medicamentos topicos para la terapia antimicotica. |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP07022353 | 2007-11-17 | ||
EP07022353.2 | 2007-11-17 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2009062746A2 WO2009062746A2 (de) | 2009-05-22 |
WO2009062746A3 true WO2009062746A3 (de) | 2009-08-13 |
Family
ID=40214317
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2008/009686 WO2009062746A2 (de) | 2007-11-17 | 2008-11-15 | Topische arzneimittel zur antimykotischen therapie |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP2222319A2 (de) |
AU (1) | AU2008323165A1 (de) |
CA (1) | CA2705815A1 (de) |
MX (1) | MX2010005385A (de) |
WO (1) | WO2009062746A2 (de) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9138393B2 (en) | 2013-02-08 | 2015-09-22 | The Procter & Gamble Company | Cosmetic compositions containing substituted azole and methods for improving the appearance of aging skin |
US9144538B2 (en) | 2013-02-08 | 2015-09-29 | The Procter & Gamble Company | Cosmetic compositions containing substituted azole and methods for alleviating the signs of photoaged skin |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9687429B2 (en) | 2007-06-20 | 2017-06-27 | The Trustees Of Columbia University In The City Of New York | Antimicrobial compositions containing low concentrations of botanicals |
US9511040B2 (en) | 2007-06-20 | 2016-12-06 | The Trustees Of Columbia University In The City Of New York | Skin and surface disinfectant compositions containing botanicals |
US8932624B2 (en) | 2007-06-20 | 2015-01-13 | The Trustees Of Columbia University In The City Of New York | Bio-film resistant surfaces |
US9981069B2 (en) | 2007-06-20 | 2018-05-29 | The Trustees Of Columbia University In The City Of New York | Bio-film resistant surfaces |
MX2012000105A (es) * | 2009-06-30 | 2012-03-14 | Univ Columbia | Composiciones antimicrobianas/conservadoras que comprenden extractos botanicos. |
IT1400726B1 (it) * | 2009-07-24 | 2013-07-02 | Vi Rus S R L | Composizione di un'emulsione ad uso topico a base di clotrimazolo, clorexidina digluconato,acido salicilico,allantoina,pantenolo,zinco,acido glicirretico,olio di mandorle dolci,olio di riso,mentile lattato indicata nel trattamento delle infezioni micotiche della cute e dei suoi annessi. |
WO2011061155A1 (en) * | 2009-11-17 | 2011-05-26 | Bayer Consumer Care Ag | Antifungal formulations and their use |
GB201107176D0 (en) * | 2011-04-28 | 2011-06-15 | Cxr Biosciences Ltd | Pyrrolnitrin derivatives |
ES2762405T3 (es) | 2011-11-03 | 2020-05-25 | Univ Columbia | Composición con actividad antimicrobiana sostenida |
US9968101B2 (en) | 2011-11-03 | 2018-05-15 | The Trustees Of Columbia University In The City Of New York | Botanical antimicrobial compositions |
WO2013086094A1 (en) | 2011-12-06 | 2013-06-13 | The Trustees Of Columbia University In The City Of New York | Broad spectrum natural preservative composition |
CN104704362B (zh) | 2012-10-09 | 2018-08-28 | 宝洁公司 | 鉴定或评估有益活性物质的方法以及包含其的组合物 |
US9726663B2 (en) | 2012-10-09 | 2017-08-08 | The Procter & Gamble Company | Method of identifying or evaluating synergistic combinations of actives and compositions containing the same |
WO2017031075A1 (en) * | 2015-08-17 | 2017-02-23 | Arno Therapeutics, Inc. | Methods and compositions for enhanced transungual delivery of ar-12 |
WO2017091167A1 (en) * | 2015-11-28 | 2017-06-01 | Pharmacti̇ve İlaç San. Ve Ti̇c. A.Ş. | Topical pharmaceutical composition comprising fusidic acid, isoconazole, dexpanthenol and hydrocortisone |
KR102217617B1 (ko) * | 2020-08-14 | 2021-02-19 | 비엘엔에이치 주식회사 | 백선의 예방 또는 치료용 약학적 조성물 |
CN113440483B (zh) * | 2021-06-30 | 2023-04-07 | 佛山市南海东方澳龙制药有限公司 | 一种犬用盐酸特比萘芬喷剂及其制备方法 |
WO2024137780A1 (en) * | 2022-12-21 | 2024-06-27 | Yale University | Pank modulators and methods of treatment using same |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2338248A1 (fr) * | 1976-01-14 | 1977-08-12 | Daunit Jeannine | Pantothenate de zinc et procede d'obtention |
RO107824B1 (ro) * | 1991-01-30 | 1994-01-31 | Maria Gaidargiu | Șampon pentru păr |
WO1999049835A1 (en) * | 1998-03-31 | 1999-10-07 | Johnson And Johnson Consumer Companies, Inc. | An acidified composition for topical treatment of nail and skin conditions |
WO2000015202A2 (de) * | 1998-09-10 | 2000-03-23 | Ipr-Institute For Pharmaceutical Research Ag | Topisch anwendbare mittel |
WO2005063224A1 (de) * | 2003-12-23 | 2005-07-14 | Merckle Gmbh | Topische zubereitungen enthaltend dimethylsulfoxid und dexpanthenol |
EP1557375A1 (de) * | 2004-01-23 | 2005-07-27 | Neubourg Skin Care GmbH & Co. KG | Nageltinktur-Sprühdose |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2003059297A2 (en) * | 2002-01-21 | 2003-07-24 | Slovakofarma A.S. | Dermatological topical compositions and a process for the preparation thereof |
-
2008
- 2008-11-15 EP EP08850735A patent/EP2222319A2/de not_active Withdrawn
- 2008-11-15 WO PCT/EP2008/009686 patent/WO2009062746A2/de active Application Filing
- 2008-11-15 CA CA2705815A patent/CA2705815A1/en not_active Abandoned
- 2008-11-15 MX MX2010005385A patent/MX2010005385A/es not_active Application Discontinuation
- 2008-11-15 AU AU2008323165A patent/AU2008323165A1/en not_active Abandoned
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2338248A1 (fr) * | 1976-01-14 | 1977-08-12 | Daunit Jeannine | Pantothenate de zinc et procede d'obtention |
RO107824B1 (ro) * | 1991-01-30 | 1994-01-31 | Maria Gaidargiu | Șampon pentru păr |
WO1999049835A1 (en) * | 1998-03-31 | 1999-10-07 | Johnson And Johnson Consumer Companies, Inc. | An acidified composition for topical treatment of nail and skin conditions |
WO2000015202A2 (de) * | 1998-09-10 | 2000-03-23 | Ipr-Institute For Pharmaceutical Research Ag | Topisch anwendbare mittel |
WO2005063224A1 (de) * | 2003-12-23 | 2005-07-14 | Merckle Gmbh | Topische zubereitungen enthaltend dimethylsulfoxid und dexpanthenol |
EP1557375A1 (de) * | 2004-01-23 | 2005-07-27 | Neubourg Skin Care GmbH & Co. KG | Nageltinktur-Sprühdose |
Non-Patent Citations (2)
Title |
---|
DATABASE WPI Week 199505, Derwent World Patents Index; AN 1995-034091, XP002511041 * |
See also references of EP2222319A2 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9138393B2 (en) | 2013-02-08 | 2015-09-22 | The Procter & Gamble Company | Cosmetic compositions containing substituted azole and methods for improving the appearance of aging skin |
US9144538B2 (en) | 2013-02-08 | 2015-09-29 | The Procter & Gamble Company | Cosmetic compositions containing substituted azole and methods for alleviating the signs of photoaged skin |
Also Published As
Publication number | Publication date |
---|---|
CA2705815A1 (en) | 2009-05-22 |
EP2222319A2 (de) | 2010-09-01 |
WO2009062746A2 (de) | 2009-05-22 |
MX2010005385A (es) | 2010-07-30 |
AU2008323165A1 (en) | 2009-05-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2009062746A3 (de) | Topische arzneimittel zur antimykotischen therapie | |
AP2405A (en) | Cannabinoid active pharmaceutical ingredient for improved dosage forms. | |
ZA200807767B (en) | Nitrogenated heterocyclic derivative, and pharmaceutical agent comprising the derivative as active ingredient | |
HK1134041A1 (en) | Medicinal composition for transdermal absorption, medicinal composition storing unit and transdermal absorption preparation using the same | |
EP2114904A4 (de) | Triazolderivate mit antipilzwirkung, verfahren zu ihrer herstellung und pharmazeutische zusammensetzung, die diese enthält | |
IL206395A (en) | N- Heterocyclic-7-Oxo-6-Sulphoxy-6,1-Diazabicyclo [1.2.3] Octane-2-Carboxamides and Pharmaceuticals Containing Them | |
DK2010190T3 (da) | Farmaceutisk opløsningsformulering til tryksatte, dosisregulerede inhalatorer | |
ZA200903160B (en) | Sulfonyl-Phenyl-2H-[1,2,4]Oxodiazol-5-one Derivatives, Processes for their preparation and their use as pharmaceuticals | |
WO2008128775A3 (en) | Stabilised pharmaceutical composition containing pregabaline | |
BRPI1009823A2 (pt) | "composição compreendendo um sistema de dispensação de droga, conjunto de uma primeira e uma segunda composição, e, kit." | |
DE502007005902D1 (de) | -methyl-19-nor-20- spirox-4-en-3-one), sowie diese enthaltende pharmazeutische präparate | |
EP2167490A4 (de) | Triazolderivate mit antipilzwirkung, verfahren zu deren herstellung und pharmazeutische zusammensetzung, die diese enthält | |
ZA200709788B (en) | Cannabinold active pharmaceutical ingredient for Improved dosage forms | |
IL209304A0 (en) | Peptides, peptidomimetics and derivatives thereof, the manufacturing thereof as well as their use for preparing a therapeutically and/or preventively active pharmaceutical composition | |
WO2007133944A3 (en) | Topical administration of acyclovir | |
EP2166015A4 (de) | Lincosamidderivat und dieses als wirkstoff enthaltendes antibakterielles mittel | |
ZA201009097B (en) | C-ring-substituted pregn-4-ene-21,17-carbolactone,and pharmaceutical preparations comprising the latter | |
WO2006128847A3 (en) | Medicament containing a betamimetic in conjunction with an anticholinergic and a pde iv inhibitor | |
WO2011014003A3 (en) | (+)-3-hydroxymorphinan derivatives as neuroprotectants | |
WO2011058336A3 (en) | Tablet comprising gum arabic | |
WO2007143456A3 (en) | Benzimidazol substituted thiophene derivatives with activity on plk | |
ZA200802187B (en) | Drug delivery system for topical administration | |
WO2009010298A8 (en) | Paullone derivatives and its use | |
IL206383A0 (en) | 15,16-methylene-17-(1'-propenyl)-17-3-oxidoestra-4-en-3'-one derivative, use thereof, and medicament containing said derivative | |
ZA200706706B (en) | Hydroxyphenol derivatives, processes for the preparation thereof, pharmaceutical compositions comprising them, and therapeutic uses thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 08850735 Country of ref document: EP Kind code of ref document: A2 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2008850735 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2705815 Country of ref document: CA Ref document number: MX/A/2010/005385 Country of ref document: MX |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2008323165 Country of ref document: AU |
|
ENP | Entry into the national phase |
Ref document number: 2008323165 Country of ref document: AU Date of ref document: 20081115 Kind code of ref document: A |